[Federal Register Volume 64, Number 43 (Friday, March 5, 1999)]
[Notices]
[Page 10725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5407]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that in a letter dated January 20, 
1999, Sigma Aldrich Research Biochemicals, Inc., Attn: Richard Milius, 
1-3 Strathmore Road, Natick, Massachusetts 01760, made application to 
the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of fentanyl (9801), a basic class of controlled substance 
in Schedule II.
    The firms plans to synthesize the fentanyl molecule to produce 
small quantities of fentanyl free base.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than May 4, 1999.

    Dated: February 23, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-5407 Filed 3-4-99; 8:45 am]
BILLING CODE 4410-09-M